
Theriva Biologics, Inc.
Theriva Biologics, Inc. (TOVX)
WebsitePrice
Market cap
Next catalystExpected Q4 2026VCN-01 + gemcitabine/nab-paclitaxel — VIRAGE2 · Enrollment completionSEC filing ↗
Cash
Chart & Events
Core Clinical
PreINDP1P2P3FilingApproved
PreINDP1P2FilingApproved
Technology Summary
Scientific context
Detailed technology interpretation
Technology advantages
Clinical
Upcoming clinical milestones
PreINDP1P2P3FilingApproved
PreINDP1P2FilingApproved
Other pipelines
PreINDP1P2P3FilingApproved
PreINDP1P2P3FilingApproved
PreINDP1P2P3FilingApproved
PreINDP1P2P3FilingApproved
Partner / License out
History / paused
PreINDP1P2P3FilingApproved
PreINDP1P2P3FilingApproved
PreINDP1P2P3FilingApproved
PreINDP1P2P3FilingApproved